The hidden costs of unrecognized and untreated depression

The estimated prevalence of depression is 40% among Americans, with nearly half (17%) of these people not realizing they are experiencing symptoms (“unrecognized depression”).  Severity of symptoms from depression and anxiety drive a significant burden, with unrecognized depression resulting in a 149% and 127% increase in medical and productivity loss costs to no depression.  

Once diagnosed, around 43% of people do not initiate treatment within a year. These delays in care can place a huge burden on the system, with costs being 2x higher for people who delay care by a year.  

In this whitepaper, you'll find and in-depth analysis of:

• Current research on the prevalence of unrecognized depression and untreated depression in the United States and the economic burden that arises from it.
• Analysis on depression symptom severity driving poor outcomes with co-occurring anxiety symptoms exacerbating costs and the economic impact of delaying care.
• The economics of Twill products at a population level from a payor and employer perspective to drive cost savings by reducing symptom severity and providing solutions that could results in earlier care.